Karyopharm to seek expanded use of multiple myeloma drug

Karyopharm to seek expanded use of multiple myeloma drug

STAT Plus: Karyopharm to seek expanded use of multiple myeloma drug following positive clinical trial

By ADAM FEUERSTEIN

The company said the primary goal was achieved in a trial designed to broaden the use of Xpovio to treat a larger number of patients with multiple myeloma.

READ MORE